McKesson (MCK) has issued an update.
McKesson Corporation is set to acquire a 70% stake in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for $2.49 billion in cash, as announced in a recent news release. The deal, which is subject to customary adjustments and regulatory review, will see McKesson taking control of a firm providing non-clinical administrative services to Florida Cancer Specialists. Investors are cautioned that forward-looking statements about the acquisition’s potential come with risks and uncertainties, and actual results could vary.
For detailed information about MCK stock, go to TipRanks’ Stock Analysis page.
